Back to Lung Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT06629714

NCT06629714
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with cancer (specifically esophageal, stomach, gastroesophageal junction, or non-small cell lung cancer) confirmed through medical tests, tissue samples, and scans
  • You have a good general level of physical functioning, scored at 80 or above on a standard medical scale (confirm with trial site)
  • Your cancer cannot be removed by surgery and has either spread locally or to other parts of the body
  • You have not yet received any systemic cancer treatments such as chemotherapy, targeted therapy, anti-angiogenic drugs, or immunotherapy
  • You have at least one tumor that can be measured on scans, according to standard medical guidelines
  • You are currently receiving or will be receiving a type of immunotherapy drug (PD-1/PD-L1 inhibitor), either alone or combined with chemotherapy
  • You are willing and able to complete questionnaires, either on your own or with help from someone else
  • You are 18 years of age or older

Who may not be able to join:

  • Your cancer is driven by a specific gene mutation (confirm with trial site)
  • You have had another type of cancer within the past 3 years
  • You currently have an acute or ongoing mental health condition
  • You are currently taking antidepressants, anti-anxiety medications, or other psychiatric medications
  • You have previously participated in another clinical drug trial
  • You have brain metastases (cancer that has spread to the brain) that are causing symptoms
  • You have a significant intellectual disability or communication difficulties that would make participation very difficult

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Anhui Medical University
Registry
clinicaltrials_gov
Start date
16 October 2020
Est. completion
20 April 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Cohort 1 & 2: Progression-free survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov